Althea 25mg CBD Softgel Capsules

Althea 25mg CBD Softgel Capsules

Althea 25mg CBD softgel capsules provide a convenient fixed-dose oral format for patients authorised to use CBD-dominant medicinal cannabis. Each softgel contains 25 mg of CBD and less than 0.25 mg of THC in a full-spectrum formulation manufactured to EU-GMP standards. This product forms part of Althea’s softgel portfolio across CBD-dominant, balanced and THC-dominant segments and is designed for patients who prefer measured capsules over tinctures or flower. The capsules cannot be smoked or vaporised and are intended strictly for oral use as directed by a prescribing practitioner.

Patients appreciate the clean presentation, absence of strong odours, and the simplicity of swallowing a single unit. As with all medicinal cannabis products, the guidance remains start low and go slow. Dose adjustments should occur only under medical supervision and in small increments. Many patients report gradual onset and extended duration of effect, supporting symptom management for chronic conditions when prescribed.

The extract is derived from carefully selected cannabis plants and processed to pharmaceutical standards. This approach yields a stable full-spectrum formulation that maintains labelled potency from manufacture through to the patient. Althea 25mg CBD softgel capsules therefore combine clinical precision with everyday practicality for those prescribed medicinal cannabis.

THC Percentage

Each Althea 25mg CBD softgel capsule contains less than 0.25 mg of delta-9-tetrahydrocannabinol. This minimal THC presence places the product firmly in the CBD-dominant category. Labelling and batch certificates confirm the stated amount falls within tight pharmaceutical tolerances. Patients receive clear, predictable dosing that supports careful use under practitioner supervision.

The low THC content suits individuals seeking the potential benefits of CBD while limiting psychoactive effects. Consistency of cannabinoid delivery helps minimise variability between doses and bottles. Regular third-party verification ensures the labelled THC content remains accurate across production runs. This reliability forms a cornerstone of patient confidence in Althea 25mg CBD softgel capsules.

CBD Percentage

Althea 25mg CBD softgel capsules deliver a precisely measured 25 mg of cannabidiol per capsule. This concentration defines the product as CBD-dominant. The substantial CBD level relative to THC supports the intended profile of the product.

Patients seeking primarily CBD-mediated outcomes often prefer this formulation. Batch testing routinely confirms CBD content remains within the stated range. This deliberate cannabinoid balance supports the intended therapeutic direction of the product while meeting applicable regulatory requirements for medicinal cannabis.

Terpene Profile

The terpene profile of Althea 25mg CBD softgel capsules reflects the full-spectrum source extract and typically includes a range of naturally occurring terpenes such as myrcene, limonene, beta-caryophyllene and pinene depending on the specific batch. These aromatic compounds contribute to the overall character of the extract even after encapsulation.

Because the product uses refined full-spectrum extract, terpene levels are present and may support the entourage effect within a controlled oral format. Patients sensitive to specific terpenes can review the accompanying certificate of analysis for the exact profile of their bottle. Careful extraction and handling help preserve these secondary compounds through the manufacturing process.

Cultivar Lineage

Althea extracts for these softgels originate from cannabis cultivars selected for consistent CBD output and favourable full-spectrum characteristics. The genetics are chosen specifically to deliver reliable cannabinoid ratios with minimal THC while retaining secondary metabolites. Lineage information appears on product documentation or certificates where available, linking the final softgels back to verified plant genetics.

Breeders and cultivators prioritise stability, yield and secondary metabolite expression when developing the input material. This attention to genetic provenance supports batch-to-batch reliability. Patients benefit from the cumulative expertise applied at the cultivation stage. The resulting extract maintains the core identity of the chosen high-CBD cultivars while meeting strict EU-GMP quality specifications.

Batch Testing

Every production lot of Althea 25mg CBD softgel capsules undergoes comprehensive third-party laboratory testing. Certificates of analysis cover cannabinoid potency, residual solvents, heavy metals, pesticides, microbial contaminants and mycotoxins. Results must meet or exceed applicable medicinal cannabis and EU-GMP standards before release.

Patients receive or can request the specific certificate matching their bottle number. This transparency allows verification of both potency and purity. Independent testing provides an additional layer of quality assurance beyond in-house controls. Consistent batch testing underpins the trust patients place in the product.

Moisture Content

Finished Althea 25mg CBD softgel capsules are manufactured and packaged to maintain low residual moisture. Controlled humidity during encapsulation and bottling protects the softgel shell integrity and oil stability. Excess moisture could compromise capsule hardness or promote degradation over time. NCBI review of cannabis and cannabinoids health effects

Storage recommendations emphasise cool, dry conditions to preserve the low-moisture state achieved at manufacture. Proper moisture management contributes directly to shelf-life reliability. Patients can therefore expect consistent performance when the product is stored as directed.

Trim Quality

Although Althea 25mg CBD softgel capsules use refined extract rather than plant material, the quality of the upstream flower remains critical. Source material is selected from carefully trimmed, high-grade cannabis that meets strict visual and chemical standards before extraction. Clean trim practices minimise chlorophyll and unwanted plant debris entering the process.

High-quality input flower translates into cleaner, more refined oil. This attention to raw material quality supports the overall purity of the finished softgels. The result is a product free from the variability sometimes associated with less carefully prepared botanical inputs.

Packaging Freshness

Seal Each bottle of Althea 25mg CBD softgel capsules features a tamper-evident freshness seal. The seal protects the contents from environmental exposure and provides clear visual confirmation that the product remains unopened. Bottles are designed to limit air and light exposure once the seal is broken.

Proper packaging helps maintain potency and physical integrity of the softgels throughout the product’s shelf life. Patients should inspect the seal upon receipt and contact the supplier immediately if any compromise is detected. The freshness seal forms a practical part of the quality chain from manufacturer to patient.

All orders ship via insured freight with signature required on delivery. Pre-shipment quality checks confirm correct product, intact packaging and valid batch documentation before dispatch. In the rare event of transit damage, a straightforward claim process covers replacement or refund under the insured terms. These measures protect both the integrity of Althea 25mg CBD softgel capsules and the patient’s investment. Browse the rest of the collection at https://medcannabiscure.shop/product-category/capsules/

Frequently Asked Questions